ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J06BA02 | BioHuman | Human normal immunoglobulin G - 50mg/ml | 7074 | 96408/11 | CLAIRYG | 10g/200ml | 1 x 200ml | Injectable solution | Infusion | Codipha | LFB Biomedicaments | France | 78,986,061 L.L | 10.71 | E1 | LFB Biomedicaments | France | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J06BA02 | BioHuman | Human normal immunoglobulin - 10g/200ml | 10062 | 92217/1 | IG VENA | 10g/200ml | 1x200ml | Injectable solution | Infusion | Macromed S.A.R.L. | Kedrion SpA | Italy | 52,191,829 L.L | 10.71 | E1 | Kedrion SpA | Italy | 2/5/2024 | 0 |
J06BA02 | BioHuman | Human normal immunoglobulin G - 10g/100ml | 6632 | 96214/11 | KIOVIG | 10g/100ml | 1 x 100ml | Injectable solution | Infusion | Abela Frères S.A.L. | Baxalta Belgium Manufacturing SA | Belgium | 52,750,347 L.L | 10.71 | E1 | Takeda Manufacturing Austria AG | Austria | 2/5/2024 | 0 |
J06BA02 | BioHuman | Human normal immunoglobulin G - 50mg/ml | 3274 | 405921 | OCTAGAM | 10g/200ml | 200ml | Injectable solution | Infusion | Mediterranean Pharmaceutical Company | Octapharma Pharmazeutika Produktions GesmbH | Austria | 69,575,612 L.L | 10.71 | E1 | 2/5/2024 | 0 | ||
J06BA02 | BioHuman | Immunoglobulin human - 10% | 9186 | 11517/1 | PRIVIGEN | 10% | 1 x 100ml | Injectable solution | Infusion | Benta Trading Co s.a.l. | Packed by Benta SAL Lebanon under license from CSL Behring AG, Switzerland | Lebanon | 80,907,645 L.L | 2.44 | E2 | 2/5/2024 | 0 |